Advanced Medical Equipment

Varian Medical Systems Inc reaffirms FY 2014 revenue guidance; lowers FY 2014 EPS guidance; gives Q3 2014 guidance; EPS guidance below analysts' estimates

Varian Medical Systems Inc:Continue to believe that total company revenues could increase by about 6 pct. to 8 pct. over the prior fiscal year for FY 2014.Expects net earnings per diluted share for FY 2014, including the $0.16 effect of the patent litigation settlement, to be in the range of $4.06...

4:05pm EDT

Titan Medical Inc closes unit offering

Titan Medical Inc:Closes public offering.Says it has sold a base offering of 10,611,469 Units and full over-allotment of 1,591,720 units for a total of 12,203,189 units at a price of C$2.10 per unit for aggregate gross proceeds of C$25,626,697.BayFront Capital Partners Ltd. acted as a selling group...

10:20am EDT

Natus Medical Inc gives Q2 2014 outlook in line with analysts' estimates; raises FY 2014 EPS outlook; reaffirms FY 2014 revenue outlook

Natus Medical Inc:Expects Q2 2014 revenue of $83-$86 mln.Expects Q2 2014 non-GAAP earnings per share of $0.24 to $0.27.Expects FY 2014 non-GAAP earnings guidance of $1.18 to $1.21, an increase from previous guidance of $1.14 to $1.18.Expects FY 2014 revenue guidance remained unchanged at $345-$350...

7:30am EDT

Bacterin International Holdings Inc announces preclinical results on use of OsteoSelect DBM Putty

Bacterin International Holdings Inc:Positive results utilizing OsteoSelect Demineralized Bone Matrix Putty bone graft for cranial defect repair has been published in peer-reviewed Journal of Craniofacial Surgery.This is first peer reviewed publication evaluating performance of OsteoSelect(reg) DBM...

7:30am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.